Peter H. Diamandis, MD
@PeterDiamandis · 28 дек. 2022 г.
• A combination of Moderna’s experimental cancer vaccine, referred as mRNA-4157/V940, and Merck’s immunotherapy called Keytruda is successful against melanoma, considered the deadliest skin cancer, reducing the risk of recurrence or death by 44% during Phase 2 clinical trials.
Elon Musk
@elonmusk
Synthetic mRNA has incredible potential!
17:25 · 28 декабря 2022 г. · 549,9 тыс. просмотров
867
248
3,6 тыс.